Literature DB >> 28436197

Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.

G P São Julião1,2, C D Ortega1,3, B B Vailati1,2, A Habr-Gama1,2,3, L M Fernandez1, J Gama-Rodrigues1,2,3, S E Araujo4, R O Perez1,2,4,5,6.   

Abstract

AIM: Full-thickness local excision after neoadjuvant chemoradiotherapy (CRT) for patients with rectal cancer and incomplete clinical response has been a treatment strategy for organ preservation. Follow-up of these patients is challenging since anatomic distortion and postoperative changes may be clinically indistinguishable from tumour recurrence. MRI may have a role in detecting recurrence. The aim of this study was to describe the MRI findings during follow-up in patients having local excision following CRT with and without local recurrence.
METHOD: The data were collected retrospectively from a single centre. Fifty-three patients with rectal cancer who had full-thickness local excision after neoadjuvant CRT and near-complete response were eligible for the study. Patients with local recurrence were treated by radical salvage surgery. The main outcome was local MRI assessment findings during follow-up.
RESULTS: Fifteen patients (five who developed local recurrence and 10 with no evidence of local recurrence) had MR images available for review and were included in the study. High signal intensity and thickening of the rectal wall were present in all patients with recurrent disease within the rectal wall. Overall, 80% of the patients with recurrence showed diffusion restriction. MRI mesorectal fascia status and circumferential resection margin showed agreement in all cases. A low signal intensity scar was seen in all patients without recurrent disease.
CONCLUSION: MRI shows high signal intensity and thickening of the rectal wall in recurrent disease in comparison to a low signal intensity fibrotic scar in non-recurrent disease. These findings may be useful in surveillance of these patients. Colorectal Disease
© 2017 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Rectal cancer; TEM; local excision; local recurrence; neoadjuvant chemoradiation

Mesh:

Year:  2017        PMID: 28436197     DOI: 10.1111/codi.13691

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  The Estimate of the Impact of Coccyx Resection in Surgical Field Exposure During Abdominal Perineal Resection Using Preoperative High-Resolution Magnetic Resonance.

Authors:  Guilherme Pagin São Julião; Cinthia D Ortega; Bruna Borba Vailati; Francisco A B Coutinho; Gustavo Rossi; Angelita Habr-Gama; Laura Melina Fernandez; Sérgio Eduardo Alonso Araújo; Gina Brown; Rodrigo Oliva Perez
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

2.  SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer.

Authors:  Evie Carchman; Daniel I Chu; Gregory D Kennedy; Melanie Morris; Marc Dakermandji; John R T Monson; Laura Melina Fernandez; Rodrigo Oliva Perez; Alessandro Fichera; Marco E Allaix; David Liska
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

Review 3.  Transanal Local Excision of Rectal Cancer after Neoadjuvant Chemoradiation: Is There a Place for It or Should Be Avoided at All Costs?

Authors:  Rodrigo Oliva Perez; Guilherme Pagin São Julião; Bruna Borba Vailati
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

Review 4.  Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer.

Authors:  Cinthia D Ortega; Rodrigo O Perez
Journal:  Insights Imaging       Date:  2019-05-30

5.  Comparison Between Size and Stage of Preoperative Tumor Defined by Preoperative Magnetic Resonance Imaging and Postoperative Specimens After Radical Resection of Esophageal Cancer.

Authors:  Zhenzhen Gao; Beibei Hua; Xiaolin Ge; Jinyuan Liu; Lei Xue; Fuxi Zhen; Jinhua Luo
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.